RDY
Dr. Reddy's Laboratories Ltd.

612
Mkt Cap
$11.97B
Volume
1.54M
52W High
$16.17
52W Low
$12.26
PE Ratio
18.45
RDY Fundamentals
Price
$14.38
Prev Close
$14.38
Open
$14.22
50D MA
$13.91
Beta
0.37
Avg. Volume
2.04M
EPS (Annual)
$0.8029
P/B
2.97
Rev/Employee
$138,447.28
$10,916.67
Loading...
Loading...
News
all
press releases
Dr. Reddy's Laboratories Ltd $RDY Shares Sold by Rhumbline Advisers
Rhumbline Advisers lowered its stake in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 24.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 277,934...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
JPMorgan Chase & Co. Has $84.27 Million Holdings in Dr. Reddy's Laboratories Ltd $RDY
JPMorgan Chase & Co. raised its position in shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 2.0% in the third quarter, according to its most recent 13F filing with the Securities...
MarketBeat·7d ago
News Placeholder
Dr. Reddys Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
Dr. Reddys Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as Dr. Reddys), today announced that the US Food and Drug...
Business Wire·10d ago
News Placeholder
Allianz Asset Management GmbH Reduces Stock Position in Dr. Reddy's Laboratories Ltd $RDY
Allianz Asset Management GmbH decreased its position in shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 84.0% during the 3rd quarter, according to its most recent filing with the...
MarketBeat·17d ago
News Placeholder
Zacks Research Brokers Decrease Earnings Estimates for RDY
Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) - Research analysts at Zacks Research reduced their FY2026 earnings estimates for shares of Dr. Reddy's Laboratories in a research note issued to...
MarketBeat·19d ago
News Placeholder
Dr. Reddy's Laboratories Ltd $RDY Shares Acquired by Bessemer Group Inc.
Bessemer Group Inc. raised its holdings in shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 30.9% in the third quarter, according to its most recent Form 13F filing with the...
MarketBeat·24d ago
News Placeholder
Dr. Reddy's Laboratories Ltd $RDY Stock Holdings Raised by Aikya Investment Management Ltd
Aikya Investment Management Ltd increased its position in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 5.7% in the third quarter, according to its most recent 13F filing with the...
MarketBeat·30d ago
News Placeholder
Dr. Reddy's Q3 Earnings Match Estimates, Revenues Rise Y/Y
RDY posts flat Q3 earnings, while revenues miss estimates as global generics growth lagged, pressured by weaker North America sales.
Zacks·1mo ago
News Placeholder
Dr. Reddy's Laboratories (NYSE:RDY) Issues Earnings Results
Dr. Reddy's Laboratories (NYSE:RDY - Get Free Report) issued its earnings results on Wednesday. The company reported $0.16 earnings per share for the quarter, meeting analysts' consensus estimates of...
MarketBeat·1mo ago
News Placeholder
Dr. Reddy's Laboratories Q3 Earnings Call Highlights
Dr. Reddy's Laboratories (NYSE:RDY) reported a resilient performance in its fiscal third quarter of FY26, with revenue growth and steady profitability despite what management described as...
MarketBeat·1mo ago
<
1
2
...
>

Latest RDY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.